44 related articles for article (PubMed ID: 2533144)
1. Emerging therapies in the medical treatment of uterine fibroids.
Goitia M; Estadella J
Med Clin (Barc); 2023 Oct; 161 Suppl 1():S32-S37. PubMed ID: 37923512
[No Abstract] [Full Text] [Related]
2. Management of uterine fibroids: Approach to medical treatment.
Huerga López C; Gutiérrez Alagüero A; Cristóbal García I
Med Clin (Barc); 2023 Oct; 161 Suppl 1():S15-S21. PubMed ID: 37923509
[No Abstract] [Full Text] [Related]
3. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
Chrisp P; Goa KL
Drugs; 1991 Feb; 41(2):254-88. PubMed ID: 1709853
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of LHRH analogue action in uterine fibroids.
Shaw RW
Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
[TBL] [Abstract][Full Text] [Related]
6. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
McClelland HR; Quinn AJ
Ulster Med J; 1992 Apr; 61(1):51-5. PubMed ID: 1535743
[TBL] [Abstract][Full Text] [Related]
7. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
West CP; Lumsden MA; Lawson S; Williamson J; Baird DT
Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
[TBL] [Abstract][Full Text] [Related]
8. The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
Van der Spuy ZM; Fieggan AG; Wood MJ; Pienaar CA
Horm Res; 1989; 32 Suppl 1():137-40. PubMed ID: 2533144
[TBL] [Abstract][Full Text] [Related]
9. Goserelin (Zoladex) in the treatment of fibroids.
West CP; Lumsden MA; Baird DT
Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():27-30. PubMed ID: 1532507
[No Abstract] [Full Text] [Related]
10. Zoladex (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy.
Miller RM; Frank RA
Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():37-41. PubMed ID: 1532509
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
